Investor Relations

Stock Quote

About SWK Holdings

We are a specialized finance company with a specific focus on opportunities in the global healthcare sector. We provide innovative capital solutions to a broad range of life science companies, institutions and inventors.

We provide capital to our business partners through our own balance sheet as well as through our investment advisory clients, which include family offices and institutional investors. Our broad capital base positions us to be the partner of choice for life science entities looking for flexible, nontraditional sources of capital.

Our management team has extensive experience specifically in healthcare-related principal investing and structured finance, resulting in a deep understanding of business opportunities in the life science sector.

For our investors, we expect to provide superior risk-adjusted returns on capital by investing in marketed ethical product cash flow streams.

Latest News
Jan 06, 2020

Acquired by SWK Holdings Corporation; Now Operating as a Wholly Owned Subsidiary Focused on Advancement of Peptelligence-Driven External Partnerships and Internal Drug Development Pipeline Entered...

Dec 09, 2019

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced the launch of their new Epic Hygiene laser at the Greater New York Dental Meeting, in New York City from Nov. 29 - Dec....

Dec 06, 2019

Boonton, NJ – December 6, 2019 – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned...

View All Releases

Latest Presentation

Fall Investor Summit Webcast and Presentation
September 16, 2019

Listen to Webcast

Upcoming & Recent Events
Monday, September 16, 2019
4:30pm EDT

View all Events

Contact Us

Maureen McEnroe
Tiberend Strategic Advisors, Inc.
(212) 375-2664


To see news related to SWK Holdings' Portfolio, click here.

Latest Quarterly Results